News
Novo Nordisk's FY 2025 guidance cuts are driven by softer U.S. Wegovy/Ozempic and GLP-1 trends. Click here to find out why I ...
21h
GlobalData on MSNWeightWatchers shuns compounded semaglutide amid FDA rules
WeightWatchers is now only offering Wegovy while other telehealth providers defiantly hang on to compounded alternatives.
Current health news includes a push for board overhaul at Avantor by Engine Capital, Ab&B Bio-Tech's share surge during its ...
Novo Nordisk A/S (NYSE:NVO) is among the. Novo Nordisk A/S (NYSE:NVO) lowered its operating profit growth projections to ...
More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the ...
Prices for Indian consumers are expected to come down significantly from the current Rs 17,000-Rs 26,000 monthly.
If you’re pregnant or hoping to become pregnant, it’s natural to have questions about your medications. And if you’re taking ...
23hon MSN
Weight loss jabs like Mounjaro and Wegovy really COULD make you go blind, researchers discover
Two of the world's most popular slimming injections may raise the risk of a sight-threatening eye disease in people with type ...
2h
Global News - Inquirer.net on MSNWill China’s home-grown obesity drugs reshape global weight loss market?
July, video editor Meng Meng, 38, has been injecting herself with a weekly weight loss drug, hoping it will finally help her ...
The gush of second quarter earnings reports is beginning to slow to a trickle, and with most of the reports in, the results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results